STERIS plc (STE) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

STERIS plc (STE) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Seeking Alpha • Sep 15, 2026

Steris (STE) Down 2.1% Since Last Earnings Report: Can It Rebound?

Steris (STE) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research • Sep 4, 2026

STERIS to Present at the Morgan Stanley Healthcare Conference

Dublin, Ireland, Sept. 01, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will participate in the Morgan Stanley Healthcare Conference in New York City on Tuesday, September 15, 2026.

GlobeNewsWire • Sep 1, 2026

Can STERIS Stock Deliver as Its $600 Million Chemistry Bet Scales?

STE is betting $600 million on a new chemistry center to boost capacity and efficiency, but higher spending and execution risks loom.

Zacks Investment Research • Aug 21, 2026

Should Investors Buy STERIS as Growth Meets Reasonable Valuation?

STE enters fiscal 2027 with solid growth, recurring healthcare demand and better margins, but tariffs and investment needs temper the valuation case.

Zacks Investment Research • Aug 20, 2026

STERIS Q1 Earnings Call Highlights

STERIS NYSE: STE reported first-quarter fiscal 2027 revenue growth and higher earnings, while maintaining its full-year outlook and outlining a $600 million investment in a new chemistry manufacturing, research and distribution complex in North Carolina.

MarketBeat • Aug 9, 2026

STERIS plc (STE) Q1 2027 Earnings Call Transcript

STERIS plc (STE) Q1 2027 Earnings Call Transcript

Seeking Alpha • Aug 6, 2026

STE Q1 Earnings Beat, Revenues Miss, Stock Dips in Aftermarket Trading

STERIS beats fiscal Q1 earnings estimates as sales rise 7.3%, but a modest revenue miss sends shares 2.4% lower after hours.

Zacks Investment Research • Aug 6, 2026

5 Quality Stocks Set to Reward Investors With Dividend Hikes

Recent dividend hikes from DRH, STE, BCC, KWR and WHD highlight financially solid companies as investors seek stability in a mixed market.

Zacks Investment Research • Aug 6, 2026

Steris to invest $600 million in new North Carolina chemicals manufacturing hub

Medical equipment maker Steris said on Wednesday it will invest $600 million to build a manufacturing ​and distribution hub in North Carolina for chemicals ‌used by healthcare and pharmaceutical customers.

Reuters • Aug 5, 2026